Bionano Genomics Inc (BNGO)
0.2211
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 12:25
Bionano Genomics Gross Profit Margin (Quarterly): -139.1% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -139.1% |
June 30, 2024 | 33.26% |
March 31, 2024 | 32.20% |
December 31, 2023 | 22.74% |
September 30, 2023 | 29.50% |
June 30, 2023 | 26.65% |
March 31, 2023 | 27.92% |
December 31, 2022 | 21.97% |
September 30, 2022 | 25.05% |
June 30, 2022 | 22.05% |
March 31, 2022 | 15.12% |
December 31, 2021 | 3.79% |
September 30, 2021 | 24.79% |
June 30, 2021 | 37.32% |
March 31, 2021 | 32.92% |
December 31, 2020 | 29.55% |
Date | Value |
---|---|
September 30, 2020 | 33.52% |
June 30, 2020 | 48.98% |
March 31, 2020 | 24.65% |
December 31, 2019 | 39.37% |
September 30, 2019 | 28.31% |
June 30, 2019 | 28.51% |
March 31, 2019 | 38.10% |
December 31, 2018 | 25.55% |
September 30, 2018 | -8.47% |
June 30, 2018 | 46.51% |
March 31, 2018 | 52.42% |
December 31, 2017 | 47.41% |
September 30, 2017 | 38.38% |
June 30, 2017 | 25.37% |
March 31, 2017 | 29.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-139.1%
Minimum
Sep 2024
48.98%
Maximum
Jun 2020
19.61%
Average
27.28%
Median
Gross Profit Margin (Quarterly) Benchmarks
Revvity Inc | 56.26% |
Bruker Corp | 48.45% |
Azenta Inc | 40.82% |
Harvard Bioscience Inc | 58.10% |
Akoya Biosciences Inc | 62.32% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -158.9% |
Return on Assets | -88.05% |
Return on Invested Capital | -121.2% |
Profit Margin (Quarterly) | -728.6% |
Operating Margin (Quarterly) | -372.6% |
Return on Net Operating Assets | -153.0% |